Intuitive Surgical Q1 results likely to be strong, says Cantor After Intuitive Surgical announced that its board has authorized an additional $1B share repurchase program and Massachusetts regulators called for increased scrutiny of robotic surgery, Cantor believes that Intuitive Surgical's risk/reward is still attractive. The firm reiterates a $575 price target and Buy rating.
Intuitive Surgical initiated with an Overweight, $575 target at Barclays Barclays analyst Matthew Taylor started shares of Intuitive Surgical with an Overweight rating and $575 price target. Taylor thinks surgery share will continue to shift to robotic and believes demand for Intuitive's da Vinci among general surgeons is very high. The stock closed yesterday down $4.17 to $492.45.